Check out CRM’s latest publication by the Clinical Operations team on trial recruitment achievement and CRM’s recruitment initiatives! Click on the link below:
Check out CRM’s latest publication by the Clinical Operations team on trial recruitment achievement and CRM’s recruitment initiatives! Click on the link below:
CRM has started its journey towards compliance to ISO 37001:2016 Anti-Bribery Management System. An awareness briefing session was held for CRM management and line managers, sharing on the standard requirements to ensure successful implementation throughout the organization.
CRM observed CMCO extension in Selangor, Putrajaya and Sabah until 9th November (CMCO has been extended until further notice.
CRM’s Clinical Operations Team have successfully conducted its very first Preparation of Regulatory Inspection Workshop on 23rd October 2020.
CRM signed an MoU with National Cancer Center Hospital Japan earlier today, witnessed by Health DDG (Research & Technical Support), Dr Hishamshah. The partnership with Japan’s top oncology hospital paves the way to progressive oncology drug development in the country and region.
Congratulations, Dr Martin and study team in SGH Heart Centre for their successful recruitment activity, being highest enrolling site globally, 2 months in a row! Together with recruitment achievement by Dr Geetha and Team from IJN, Malaysia has climbed the rank to being the topmost country alongside USA in the enrollment leaderboard for a global Pulmonary Arterial Hypertension (PAH) study.
MREC together with CRM conducted the very first MREC Good Submission Practice Training via Zoom on 3rd November 2020. Presented by Dr Lee Keng Yee (MREC Secretary), the training was focused on sponsored research ethics submission to MREC via NMRR.
CRM observes CMCO in effect in all states within Peninsular Malaysia (except Perlis, Pahang and Kelantan) & in Sabah, until end of CMCO/further notice.
Congratulations to Dr Koh Keng Tat and study team at Sarawak Heart Centre for successfully enrolling first patient in Malaysia for a sponsored medical device study despite the Covid-19 pandemic.
CRM have just completed its 2nd Protocol Compliance Workshop on 17th November 2020. The workshop, conducted by Dr Lee Keng Yee (MREC) and Carrie Koh (Paraxel), was aimed to provide insights on protocol deviation and how to reduce them.